Development and Validation of a Penicillin Allergy Clinical Decision Rule

Overview of attention for article published in JAMA Internal Medicine, May 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news: 31 news outlets
blogs: 3 blogs
policy: 1 policy source
twitter: 183 X users
facebook: 6 Facebook pages

wikipedia: 1 Wikipedia page
reddit: 1 Redditor
f1000: 1 research highlight platform
guideline: 5 clinical guideline sources
podcasts: 6 podcasts

Readers on

mendeley: 324 Mendeley

So far, Altmetric has seen 11 public wall posts from 6 users.

JAMA Internal Medicine, 03 Aug 2020

This diagnostic study develops and validates a penicillin allergy clinical decision rule that enables point-of-care risk…

JAMA Internal Medicine, 10 Jun 2020

This diagnostic study develops and validates a penicillin allergy clinical decision rule that enables point-of-care risk…

JAMA Internal Medicine, 29 May 2020

PEN-FAST may aid the risk stratification of patients with penicillin allergy to facilitate implementation of delabeling…

JAMA Internal Medicine, 29 May 2020

This diagnostic study develops and validates a penicillin allergy clinical decision rule that enables point-of-care risk…

This page shows the most recent Facebook posts that mention this research output. Click here to find out how to access more activity, including 7 additional Facebook posts.